Health News

Bird Flu Concern Prompts U.S. to Award Moderna $176 Million for

Bird Flu Concern Prompts U.S. to Award Moderna 6 Million for


Originally published on www.childrenshealthdefense.org

The Defender’s Big Pharma Watch delivers the latest headlines related to pharmaceutical companies and their products, including vaccines, drugs, and medical devices and treatments. The views expressed in the below excerpts from other news sources do not necessarily reflect the views of The Defender. Our goal is to provide readers with breaking news that affects human health and the environment.

Bird Flu Concern Prompts U.S. to Award Moderna $176 Million for Vaccine Development

Reuters reported:

The U.S. government has awarded $176 million to Moderna (MRNA.O) to advance the development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.

Shares of the Cambridge, Massachusetts-based company rose more than 2% to $118.32 in early trade.

The funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza, the company said in a statement.

Last year, Moderna started a safety and immunogenicity study of its bird flu vaccine called mRNA-1018 in healthy adults aged 18 and older. That study included both the H5 subtype of bird flu that is currently circulating in dairy cattle, as well as the H7 bird flu subtype. Results of that study are expected this year and will be used to map out late-stage development plans, the company said. Moderna’s vaccine uses mRNA or messenger RNA, the technology in its COVID-19 shot.

Scientist Defeats J&J Lawsuit Over Cancer Research

Reuters reported:

A New Jersey federal judge has dismissed a lawsuit brought by a Johnson & Johnson subsidiary against a scientist who published a paper linking talc-based consumer products to cancer, finding that the research was not fraudulent or libelous.

U.S. District Judge Georgette Castner on Friday found that Dr. Jacqueline Moline, the chair of occupational medicine at Northwell Health, did not engage in fraud, libel or false advertising when she published an influential 2020 paper concluding that exposure to asbestos-contaminated talcum powder products can cause mesothelioma.

Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button